Health.Global's Financial Report Shows Negative Performance in Q4 2023

Healthcare Global Enterprises (Health.Global), a midcap healthcare services company, recently declared its financial results for the quarter ending December 2023. The company's stock has been given a 'Sell' call by MarketsMOJO. According to the financial report, Health.Global has seen a negative performance in the quarter, with a score of -7 compared to 26 in the previous quarter. This decline can be attributed to various factors, including a decrease in profit before tax (PBT) and profit after tax (PAT), as well as a low operating profit to interest ratio. The company's PBT has fallen by 34.77% year on year, while the PAT has decreased by 24.4% year on year. This trend is expected to continue in the near term. Additionally, the company's ability to manage interest payments has deteriorated, with the lowest operating profit to interest ratio in the last five quarters. Furthermore, the company's income from non-business activities is high, accounting for 54.88% of its PBT. This may not be a sustainable business model in the long run. The earnings per share (EPS) have also decreased, indicating declining profitability and lower returns for shareholders. In terms of financial management, Health.Global has a high debt-equity ratio, indicating that it is borrowing more to fund its operations. This could potentially lead to a stressed liquidity situation. The company's pace of settling its debtors has also slowed, with the lowest debtors turnover ratio in the last five half-yearly periods. It is worth noting that the company's non-operating income has increased, with the highest amount recorded in the last five quarters. However, this may not be a sustainable source of income for the company. Overall, the financial results for the quarter ending December 2023 show a negative performance for Health.Global. Investors are advised to carefully consider these factors before making any investment decisions.